Pfizer isn’t the only company seeking to lower the age limit for its vaccine. Results also are expected soon from Moderna’s vaccine study in 12 to 17-year-olds.

Canadian trials have just begun for a prospective COVID-19 vaccine but its Quebec-based manufacturer is already tempering expectations.